Highlights

MediaPharma S.r.l.
A Company focused on the discovery and development of innovative drugs for the treatment of cancer and other diseases with unmet medical need.

MP-GAL-3BP

 

Gal-3BP in serum/saliva of COVID-19 infected subjects

Gal-3BP is a multifunctional secreted protein of the innate immunity which is induced in cancer and viral infection.

Scientists at MediaPharma have identified Gal-3BP in serum or saliva as a predictive biomarker allowing doctors to screen COVID-19 infected subject who will develop severe complications and ICU.

 

 

 

I commenti sono chiusi.

Company

R&D

Careers

Business